|
Volumn 50, Issue 2, 2002, Pages 117-120
|
Anti-Erwinia asparaginase antibodies during treatment of childhood acute lymphoblastic leukemia and their relationship to outcome: A case-control study
a a,c a,b a,d a,e a,f a |
Author keywords
Antibody; Child; Erwinia asparaginase; Leukemia; Relapse
|
Indexed keywords
ASPARAGINASE;
BACTERIAL ENZYME;
ENZYME ANTIBODY;
ACUTE LYMPHOBLASTIC LEUKEMIA;
ADOLESCENT;
ANTIBODY PRODUCTION;
ARTICLE;
CANCER RECURRENCE;
CANCER REGRESSION;
CANCER RISK;
CASE CONTROL STUDY;
CHILD;
CLINICAL ARTICLE;
CONTROLLED STUDY;
ENZYME LINKED IMMUNOSORBENT ASSAY;
ERWINIA;
FEMALE;
FOLLOW UP;
HIGH RISK POPULATION;
HUMAN;
MAINTENANCE THERAPY;
MALE;
PRIORITY JOURNAL;
STATISTICAL SIGNIFICANCE;
TREATMENT OUTCOME;
ADOLESCENT;
ANTIBODIES, BACTERIAL;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
ASPARAGINASE;
BACTERIAL PROTEINS;
CASE-CONTROL STUDIES;
CHILD;
CHILD, PRESCHOOL;
ENZYME-LINKED IMMUNOSORBENT ASSAY;
ERWINIA;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
INFANT;
LEUKEMIA, LYMPHOCYTIC, ACUTE, L1;
MALE;
RANDOM ALLOCATION;
RISK;
TREATMENT OUTCOME;
|
EID: 0036351278
PISSN: 03445704
EISSN: None
Source Type: Journal
DOI: 10.1007/s00280-002-0466-y Document Type: Article |
Times cited : (16)
|
References (11)
|